Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigator Unitsort descending Sponsor Date
Prescribing Vitamin D: An Exploratory Comparative Survey of University of Arizona Integrative Medicine Fellows' Attitudes and Practices Contract $101,919.00 Research Lisa Alschuler Andrew Weil Ctr Intgrtv Med Pharmavite 01/2020
Validation of Spinal Neurotensin Receptor 2 as an Analgesic Target Grant $1,539,731.00 Research Amol Patwardhan Anesthesiology National Institute of Neurological Disorders and Stroke 10/2020
Technical Study: Analytical Performance Evaluation of Cobas Plus Contract $553,527.00 Clinical Trial Ryan Matika Anesthesiology Roche Diagnostics Operations, Inc. 10/2020
Coronavirus Telehealth Resource Centers Grant $828,571.00 Other Sponsored Activity Ronald Weinstein Arizona Telemedicine Program Health Resources and Services Administration 06/2020
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 with Placebo and with Tofacitinib in Combination with Conventional Synthetic DMARDs.... Contract $314,050.00 Clinical Trial Chian Kwoh Arthritis Center-Research IQVIA RDS Inc. 03/2020
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients with Diffuse Cutaneous Systemic Sclerosis or Systemic Sclerosis-Associated... Contract $55,928.00 Clinical Trial Chian Kwoh Arthritis Center-Research Cumberland Pharmaceuticals, Incorporated 07/2020
Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life Grant $6,030,330.00 Research Fernando Martinez Asthma/Airway Disease Rsch Ctr National Heart, Lung, and Blood Institute 04/2020
AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED) Cooperative Agreement $1,466,425.00 Research Fernando Martinez Asthma/Airway Disease Rsch Ctr National Heart, Lung, and Blood Institute 09/2020
Beyond Pseudotime: Enhanced Single-cell GEnomics Tools for Understanding the Temporal Dynamics of Development and Disease Grant $1,822,950.00 Research Darren Cusanovich Asthma/Airway Disease Rsch Ctr National Institute of General Medical Sciences 08/2020
Binational Early Asthma & Microbiome Study (BEAMS) Grant $15,309,471.00 Research Fernando Martinez Asthma/Airway Disease Rsch Ctr National Institute of Allergy and Infectious Disease 08/2020
Epitope Open-Label Extension Study to Evaluate the Long-Term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children (EPOPEX) Contract $173,290.72 Clinical Trial Heather Cassell Asthma/Airway Disease Rsch Ctr Pharmaceutical Research Associates 02/2020
Development of Surfactant Protein A-derived Peptidomimetics for the Treatment of Asthma Grant $86,381.00 Research Scott Boitano Asthma/Airway Disease Rsch Ctr RaeSedo, LLC 09/2020
Octapharma's Octagam 10% Gam10-09 Study Contract $64,944.00 Research Michael Daines Asthma/Airway Disease Rsch Ctr Octapharma Pharmazeutika Produktionsgesellschaft mbH (Austria) 08/2020
A Phase 2, Double-Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses.... Contract $273,767.50 Clinical Trial Cori Daines Asthma/Airway Disease Rsch Ctr Janssen Research & Development, LLC 01/2020
Immunometabolic Phenotypes in Adult Severe Asthma and Disease Progression Cooperative Agreement $339,110.00 Research Deborah Meyers Asthma/Airway Disease Rsch Ctr Brigham and Women's Hospital 09/2020
B Cell-Adaptive Immune Profile in Emphysema-Predominant COPD Grant $3,364,046.00 Research Francesca Polverino Asthma/Airway Disease Rsch Ctr National Heart, Lung, and Blood Institute 07/2020
Area Health Education Centers Program COVID Grant $95,455.00 Instruction Daniel Derksen AZ Health Education Centers Health Resources and Services Administration 06/2020
A Phase II Trial of PET-Directed Therapy using AVD (Doxorubicin, Vinblastine, and Dacarbazine) Plus Brentuximab Vedotin Induction Chemotherapy, with or without Brentuximab Vedotin Plus Nivolumab, Foll Contract $40,100.00 Clinical Trial Abhijeet Kumar Cancer Center Division Mayo Foundation for Medical Education and Research (Mayo Clinic) 06/2020
A Phase I/II Pilot Trial, Single Arm, Open Label, of Protein-bound Paclitaxel, Cisplatin, And Gemcitabine (GCN) Combined with Tumor Treatment Fields (TTF) in Patient with Metastatic Pancreatic... Contract $161,422.69 Clinical Trial Hani Babiker Cancer Center Division NovoCure 09/2020
Evaluation of Reglagene Compounds in Cancer Cell Lines with DNA Damage Mutations Contract $2,000.00 Research Joann Sweasy Cancer Center Division Reglagene, LLC 10/2020
Imagestream-X MKII to Enhance Cell Biology Research Grant $596,093.00 Research Deepta Bhattacharya Cancer Center Division National Institutes of Health 07/2020
A Phase 1/2 Study of ZN-c3 as a Single Agent in Combination with Talazoparib or Pembrolizumab in Patients with Solid Tumors Contract $138,409.52 Clinical Trial Pavani Chalasani Cancer Center Division K-Group Beta, Inc. 03/2020
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with Either Durvalumab Monotherapy or Durvalumab Plus Bevacizumab Contract $208,612.70 Clinical Trial Gregory Woodhead Cancer Center Division Astrazeneca 06/2020
A Phase 2 Open-Label Study of Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-cell Lymphoma (PTCL) in Adults Age 60 and Above Contract $147,691.00 Clinical Trial Daniel Persky Cancer Center Division Seattle Genetics, Incorporated 05/2020
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants with Previously Treated Locally Advanced/Metastatic or Surgically Unresectable.. Contract $171,440.00 Clinical Trial Aaron Scott Cancer Center Division Incyte Corporation 05/2020

Pages